Table 5 The statistical comparisons and effect sizes of symptom reduction from baseline.
Day 5 | 2-month follow-up | |||
---|---|---|---|---|
Outcome\treatment | tACS | Sham | tACS | Sham |
AHRS | t13 = 0.416 | t10 = −0.089 | t13 = −1.68 | t10 = −0.792 |
p = 0.658 | p = 0.465 | p = 0.058† | p = 0.223 | |
d = 0.111 | d = −0.026 | i = −0.450 | i = −0.239 | |
HPSVQ | t13 = −0.28 | i10 = −1.69 | t13 = −1.16 | t10 = −2.08 |
p = 0.390 | p = 0.060† | p = 0.134 | p = 0.032* | |
d = −0.076 | d = −0.511 | d = −0.309 | d = −0.628 | |
PANSS | ||||
–total | t13 = −1.87 | t10 = −0.451 | t13 = −1.18 | t10 = −2.43 |
p = 0.042* | p = 0.331 | p = 0.130 | p = 0.018* | |
d = −0.499 | d = −0.136 | d = −0.314 | d = −0.734 | |
–Positive symptoms | t13 = −1.06 | t10 = −0.396 | t13 = −1.11 | t10 = −2.14 |
p = 0.155 | p = 0.350 | p = 0.143 | p = 0.029* | |
d = −0.283 | d = −0.120 | d = −0.297 | d = −0.645 | |
–Negative symptoms | t13 = 0 | t10 = 0.1 | t13 = 0.764 | t10 = −1.69 |
p = 0.5 | p = 0.539 | p = 0.771 | p = 0.060† | |
d = 0 | d = 0.030 | d = 0.204 | d = −0.512 | |
–General psychopathology | t13 = −2.58 | t10 = −0.470 | t13 = −1.98 | t10 = −1.87 |
p = 0.011* | p = 0.324 | p = 0.034* | p = 0.046* | |
d = −0.690 | d = −0.142 | d = −0.530 | d = −0.563 | |
–Hallucinations | t13 = 0 | t10 = −0.559 | t13 = −1.38 | t10 = −1 |
p = 0.5 | p = 0.294 | p = 0.095† | p = 0.170 | |
d = 0 | d = −0.169 | d = −0.370 | d = −0.302 |